Reuters logo
BRIEF-FDA approves Pfizer's Lyrica® CR extended-release tablets CV
October 12, 2017 / 12:14 PM / 6 days ago

BRIEF-FDA approves Pfizer's Lyrica® CR extended-release tablets CV

Oct 12 (Reuters) - Pfizer Inc

* Pfizer Inc - ‍U.S. FDA approves Lyrica CR extended-release tablets CV​

* Says ‍Lyrica CR did not receive approval for management of fibromyalgia​

* Pfizer inc - ‍lyrica cr did not receive approval for management of fibromyalgia​

* Pfizer - in PHN study, 73.6% of patients in Lyrica CR group achieved at least 50% improvement in pain intensity compared with 54.6% in placebo group Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below